August 8, 2017
Gradient will present at Product Stewardship on November 2-4, 2017 in Tampa, FL.
The Product Stewardship conference brings together prominent product stewardship professionals to present and discuss global emerging issues, case studies, practical experiences, and new developments. Gradient’s presentations include:
“Around the World with Your New Chemicals.”
Jessie M. Kneeland, Ph.D.
Thursday, November 2, 1:30 – 2:30 PM
This will be an interactive session where participants will take a trip around the world through the perspective of several new chemicals, learning how to expedite their travel by overcoming potential barriers to entry. By learning from each other’s experience and expertise, the audience will gain familiarity with evolving regulations in key markets as they practice developing a global registration strategy for new chemicals.
“Hazard Assessment: Building Blocks of Compliance and Proactive Product Stewardship.”
Ari S. Lewis, M.S.
Friday, November 3, 1:30 – 2:30 PM
Regulatory agencies and companies are increasingly committed to characterizing and communicating chemical hazards to workers and the public. This session will cover obstacles to arriving at sound hazard conclusions, methods of conducting a robust hazard management program, and communicating consistent, supportable hazard information internally and to the public. Real-world examples of compliance challenges will be used, focused on evaluation and documentation approaches when only conflicting or incomplete chemical information is available.
“How to Avoid Animal Testing in Your Chemical Registration.”
Jiaru Zhang, M.P.H.
Saturday, November 4, 9:30 AM – 10:30 AM
To respond to recent regulations aimed at reducing and replacing the use of vertebrate animals in chemical testing, we will discuss methods to fill data gaps and estimate potential toxicity for chemicals with limited or no data. This session will also outline the broad regulatory landscape of chemical testing requirements and acceptance of animal testing alternatives (e.g., read-across, in vitro testing, quantitative structure-activity relationship [QSAR] models, weight-of-evidence analyses, and data waiving) when registering new industrial chemicals in worldwide jurisdictions.